Similar articles for PMID: 26307384

Year	Number of Results
1998	2
2002	1
2004	1
2006	1
2007	5
2008	4
2009	6
2010	7
2011	11
2012	11
2013	9
2014	4
2015	8
2019	1
2020	1
2024	0

1

Sunitinib monotherapy instead of mitotane combination therapy for the treatment of refractory adrenocortical carcinoma.

Zhuang J, Wang D, Wu R, Tu X, Chen Y, Qiu S. Zhuang J, et al. Int J Urol. 2015 Nov;22(11):1079-81. doi: 10.1111/iju.12903. Epub 2015 Aug 25. Int J Urol. 2015. PMID: 26307384 No abstract available.

2

Sunitinib in refractory adrenocortical carcinoma: a phase II, single-arm, open-label trial.

Kroiss M, Quinkler M, Johanssen S, van Erp NP, Lankheet N, Pöllinger A, Laubner K, Strasburger CJ, Hahner S, Müller HH, Allolio B, Fassnacht M. Kroiss M, et al. J Clin Endocrinol Metab. 2012 Oct;97(10):3495-503. doi: 10.1210/jc.2012-1419. Epub 2012 Jul 26. J Clin Endocrinol Metab. 2012. PMID: 22837187 Clinical Trial.

3

Successful treatment of adrenocortical carcinoma with pulmonary metastasis in a child: report of a case.

Arai H, Rino Y, Yamanaka S, Yukawa N, Wada N, Kato H, Yanagimachi M, Goto H, Oshiro H, Yamanaka S, Inayama Y, Lee J, Masuda M. Arai H, et al. Surg Today. 2008;38(10):965-9. doi: 10.1007/s00595-008-3788-5. Epub 2008 Sep 27. Surg Today. 2008. PMID: 18820878

4

[A case of complete response of multiple lung metastases of renal cell carcinoma with the flexible administration of sunitinib].

Kim H, Shoji S, Usui Y, Nagata Y, Terachi T, Uchida T. Kim H, et al. Hinyokika Kiyo. 2013 Jan;59(1):7-10. Hinyokika Kiyo. 2013. PMID: 23412117 Free article. Japanese.

5

Adrenocortical carcinoma.

Baudin E; Endocrine Tumor Board of Gustave Roussy. Baudin E, et al. Endocrinol Metab Clin North Am. 2015 Jun;44(2):411-34. doi: 10.1016/j.ecl.2015.03.001. Endocrinol Metab Clin North Am. 2015. PMID: 26038209 Review.

6

Sunitinib: the next advance in small-cell lung cancer?

Leighl NB. Leighl NB. J Clin Oncol. 2015 May 20;33(15):1637-9. doi: 10.1200/JCO.2014.60.1815. Epub 2015 Apr 13. J Clin Oncol. 2015. PMID: 25870089 No abstract available.

7

Contemporary management of adrenocortical carcinoma.

Zini L, Porpiglia F, Fassnacht M. Zini L, et al. Eur Urol. 2011 Nov;60(5):1055-65. doi: 10.1016/j.eururo.2011.07.062. Epub 2011 Aug 4. Eur Urol. 2011. PMID: 21831516 Review.

8

Surgical management of adrenocortical carcinoma.

Ranvier GG, Inabnet WB 3rd. Ranvier GG, et al. Endocrinol Metab Clin North Am. 2015 Jun;44(2):435-52. doi: 10.1016/j.ecl.2015.02.008. Epub 2015 Mar 17. Endocrinol Metab Clin North Am. 2015. PMID: 26038210 Review.

9

Metastatic adrenocortical carcinoma with a prolonged response to mitotane.

Pal SK, Gartrell B, Olsson CA, Stein CA. Pal SK, et al. Oncology (Williston Park). 2014 Jul;28(7):624-5, 642. Oncology (Williston Park). 2014. PMID: 25144285 Free article. No abstract available.

10

[Recent advances in the treatment of adrenocortical carcinomas].

Ducry J, Berthold D, Pralong F. Ducry J, et al. Rev Med Suisse. 2012 Nov 14;8(362):2181-4, 2186. Rev Med Suisse. 2012. PMID: 23240320 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

67 results

Results by year